ClearGage Revenue and Competitors

Claim your profile

Carrollwood, FL USA

Location

N/A

Total Funding

Fintech

Industry

Estimated Revenue & Valuation

  • ClearGage's estimated annual revenue is currently $17.6M per year.(i)
  • ClearGage's estimated revenue per employee is $210,000

Employee Data

  • ClearGage has 84 Employees.(i)
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.1M35N/AN/AN/A
#2
$44.8M166N/AN/AN/A
#3
$36.5M135N/AN/AN/A
#4
$3.8M14N/AN/AN/A
#5
$130.1M0N/A$96.2MN/A
#6
$12.6M0N/A$37.8MN/A

keywords:N/A

N/A

Total Funding

84

Number of Employees

$17.6M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

ClearGage News

2022-04-17 - ClearGage announces launch of new brand identity

Founded in 2009, ClearGage has a thirteen-year track record of innovation in healthcare financial technology. The company's early offering was...

2022-03-22 - ClearGage recognized as one of the world’s 100 fastest-growing Gator businesses

ClearGage was co-founded by UF alumni John Zdanowicz Jr. (BSBA '94, MBA '99) along with Chip Hunziker in 2009. As a financial technology...

2021-10-08 - GrowFL Announces 11th Annual Florida Companies To Watch

TAMPA, Fla. (PRWEB) October 08, 2021 ClearGage, a leader in healthcare payments technology and patient financing, is pleased to be among the top 50 second-stage companies in Florida selected as a 11th Annual GrowFL Florida Companies to Watch honorees, a statewide competition that identifies com ...

2021-08-16 - Eye Care Leaders and ClearGage Partner to Enhance Patient Payment Experience

TAMPA, Fla. (PRWEB) August 16, 2021 Eye Care Leaders, the leading technology solutions provider in the ophthalmic and optometric markets, and ClearGage, a leading provider of patient payment technology, have established a partnership to provide users of Eye Care Leaders access to a suite of pay ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$50.8M1661%$14.4M
#2
$34.2M170N/AN/A
#3
$28M193N/AN/A
#4
$114.1M454-2%N/A